PIRTOBRUTINIB MONOTHERAPY IN BRUTON TYROSINE KINASE INHIBITOR-INTOLERANT PATIENTS WITH B-CELL MALIGNANCIES: RESULTS OF THE PHASE I/II BRUIN TRIAL

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Bruton tyrosine kinase inhibitors (BTKi) have transformed the treatment of B-cell malignancies, but intolerance has often led to their discontinuation.The phase 1/2 BRUIN study evaluated pirtobrutinib, a highly selective non-covalent (reversible) BTKi, Shower Caps in patients with R/R B-cell malignancies (NCT03740529).Pirtobrutinib was investigated

read more


The Influence of Post-Internet on the Aesthetics of Vaporwave

While the cultural phenomenon known as vaporwave is commonly traced back to 2009, its defining characteristics remain a subject of ongoing debate within both popular culture and academic circles.Various perspectives categorize it Blood Pressure - Cuff and Stethoscope Sets as a microgenre of electronic music, a meme, an art movement, a critique of c

read more